Home >> Tag Archives: DeNovo Sciences—

Tag Archives: DeNovo Sciences—

BioTheranostics, DeNovo join for liquid biopsy work

Oct. 26, 2015—BioTheranostics announced a collaboration agreement with DeNovo Sciences, a player in the emerging liquid biopsy field, to investigate the technical feasibility of using BioTheranostics’ proprietary biomarkers in the development of blood-based diagnostics. These proof-of-concept studies will leverage proprietary platforms to enable molecular characterization with BioTheranostics biomarkers using circulating tumor cells enriched and captured with DeNovo’s microfluidic platform to ...

Read More »

DeNovo Sciences publishes on CTC technology, 7/14

July 2014—DeNovo Sciences published “A novel microchannel-based device to capture and analyze circulating tumor cells (CTCs) of breast cancer.” DeNovo’s scientific team explored microfluidic capture techniques for isolating CTCs, which resulted in the development of proprietary technology to accomplish rare cell capture and analysis.

Read More »
X